文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

澳大利亚成人肺炎球菌免疫规划变化对侵袭性肺炎球菌疾病的影响

The impact of the changing pneumococcal national immunisation program among older Australians.
PubMed 文献 · Vaccine · 2020-12-29

该研究分析了2002至2017年澳大利亚全国法定传染病监测系统中原住民与非原住民成人的侵袭性肺炎球菌疾病(IPD)通报数据。自2005年婴儿和成人肺炎球菌疫苗普遍资助后,非原住民≥65岁成人总IPD下降19%,但原住民≥50岁成人总IPD翻倍。疫苗血清型IPD显著下降(除外血清型3),但被非PCV血清型替代,血清型3目前是老年人中最常见血清型。

要点

  • 澳大利亚婴儿和成人肺炎球菌疫苗接种计划塑造了老年人IPD的血清型特异性流行病学。
  • 非原住民≥65岁成人总IPD下降19%,而原住民≥50岁成人总IPD翻倍,原住民负担仍显著。
  • PCV血清型(除外血清型3)IPD显著下降,但非PCV血清型替代明显,血清型3为老年人最常见。

核心结论

  • 澳大利亚婴儿和成人肺炎球菌疫苗接种计划塑造了老年人IPD的血清型特异性流行病学。
  • IPD仍是原住民人群的显著健康负担,PCV血清型(除外血清型3)的群体免疫效应明显,非PCV血清型替代 evident。

研究设计与样本

  • 研究分析了2002至2017年澳大利亚全国法定传染病监测系统(NNDSS)的IPD通报数据。
  • 数据按年龄、疫苗血清型组和原住民状态分组。

主要发现

  • 自2005年1月普遍资助婴儿和老年人肺炎球菌疫苗接种计划以来,非原住民≥65岁成人总IPD下降19%,但原住民≥50岁成人总IPD翻倍。
  • 两组疫苗覆盖率均不理想,原住民成人更低。
  • PCV血清型(除外血清型3)IPD在研究期间显著下降,但被非PCV血清型替代;血清型3目前是老年人中最常见血清型。

临床怎么用

  • 应关注原住民成人IPD负担增加,并提高肺炎球菌疫苗覆盖率。
  • 需监测非PCV血清型替代和血清型3的流行病学变化。
  • 提高成人23vPPV覆盖率可能有助于控制其独有血清型IPD。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Australia has a universal infant pneumococcal conjugate vaccination program and until recently a universal pneumococcal polysaccharide vaccine program for non-Indigenous adults aged ≥65 years and Indigenous adults aged ≥50 years. We documented the impacts of infant and adult vaccination programs on the epidemiology of invasive pneumococcal disease (IPD) in Indigenous and non-Indigenous adults. IPD notifications from the National Notifiable Disease Surveillance System were analysed from 2002 to 2017, grouped by age, vaccine serotype group and Indigenous status. Since the universal funding of infant and elderly pneumococcal vaccination programs in January 2005, total IPD decreased by 19% in non-Indigenous adults aged ≥65 years but doubled in Indigenous adults aged ≥50 years. Vaccine uptake was suboptimal in both groups but lower in Indigenous adults. IPD due to the serotypes contained in the pneumococcal conjugate vaccines (PCV) except for serotype 3 declined markedly over the study period but were replaced by non-PCV serotypes. Serotype 3 is currently the most common in older adults. In the populations eligible for the adult 23-valent pneumococcal polysaccharide vaccine (23vPPV) program, IPD rates due to its exclusive serotypes increased to a lower extent than non-vaccine types. In 2017, non-vaccine serotypes accounted for most IPD in the older population eligible for the 23vPPV program, while it's eleven exclusive serotypes accounted for the majority of IPD in younger adults. Infant and adult pneumococcal vaccination programs in Australia have shaped the serotype-specific epidemiology of IPD in older adults. IPD remains a significant health burden for the Indigenous population. Herd immunity impact is clear for PCV serotypes excluding serotype 3 and serotype replacement is evident for non-PCV serotypes. The adult 23vPPV immunisation program appears to have partially curbed replacement with IPD due to its eleven exclusive serotypes, highlighting a potential benefit of increasing adult 23vPPV coverage in Australia.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Menzies R, Stein AN, Booy R, et al. The impact of the changing pneumococcal national immunisation program among older Australians. Vaccine. 2020. PMID: 33384189. doi:10.1016/j.vaccine.2020.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。